Zoetis (ZTS) Cash from Operations (2012 - 2026)
Zoetis' (ZTS) quarterly Cash from Operations came in at 401000000.0 in Q1 2026, down 22.14% year-on-year from 515000000.0 in Q1 2025, and down 55.1% on a QoQ basis from 893000000.0 in Q4 2025.
Zoetis (ZTS) Cash from Operations (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Cash from Operations data on file, last reported at 401000000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations fell 22.14% year-over-year to 401000000.0 in Q1 2026; TTM through Mar 2026 was 2790000000.0, a 2.89% decrease from a year earlier, with the FY2025 full-year figure at 2904000000.0, down 1.66% from the prior year.
- Cash from Operations for Q1 2026 stood at 401000000.0, down from 893000000.0 in the prior quarter.
- Over the last five years, Cash from Operations for ZTS reached as high as 951000000.0 in Q3 2024 and fell as low as 183000000.0 in Q2 2023.
- Historically, Cash from Operations has averaged 619000000.0 across 5 years, with a median of 558000000.0 in 2025.
- Across the five-year window, Cash from Operations tumbled 45.54% in 2023 and surged 174.32% in 2024, its largest moves.
- Year by year, Cash from Operations stood at 741000000.0 in 2022, then rose by 21.05% to 897000000.0 in 2023, then rose by 0.89% to 905000000.0 in 2024, then fell by 1.33% to 893000000.0 in 2025, then plunged by 55.1% to 401000000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 401000000.0 in Q1 2026, 893000000.0 in Q4 2025, and 938000000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 11.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 401.00 Mn |
| Mar 31, 2026 | 401.00 Mn |
| Dec 31, 2025 | 893.00 Mn |
| Dec 31, 2025 | 893.00 Mn |
| Sep 30, 2025 | 938.00 Mn |
| Sep 30, 2025 | 938.00 Mn |
| Jun 30, 2025 | 558.00 Mn |
| Jun 30, 2025 | 558.00 Mn |
| Mar 31, 2025 | 515.00 Mn |
| Mar 31, 2025 | 515.00 Mn |
| Dec 31, 2024 | 905.00 Mn |
| Dec 31, 2024 | 905.00 Mn |
| Sep 30, 2024 | 951.00 Mn |
| Sep 30, 2024 | 951.00 Mn |
| Jun 30, 2024 | 502.00 Mn |
| Jun 30, 2024 | 502.00 Mn |
| Mar 31, 2024 | 595.00 Mn |
| Mar 31, 2024 | 595.00 Mn |
| Dec 31, 2023 | 897.00 Mn |
| Dec 31, 2023 | 897.00 Mn |